References
- Pradat PF, Camdessanché JP, Carluer L, Cintas P, Corcia P, Danel-Brunaud V, . Actualités dans la recherche fondamentale et clinique sur la sclerose laterale amyotrophique. Rev Neurol (Paris). 2009;165:532–41.
- Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
- Mendonça DM, Chimelli L, Martinez AM. Quantitative evidence for neurofilament heavy subunit aggregation in motor neurons of spinal cords of patients with amyotrophic lateral sclerosis. Braz J Med Biol Res. 2005;38:925–33.
- Alves-Rodrigues A, Gregori L, Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998;21:516–20.
- de Martino GN, Slaughter CA. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem. 1999;274:22123–6.
- Mendonça DM, Chimelli L, Martinez AM. Expression of ubiquitin and proteasome in motorcneurons and astrocytes of spinal cords from patients with amyotrophic lateral sclerosis. Neurosci Lett. 2006;404:315–9.
- Shibata N, Kobayashi M. The role for oxidative stress in neurodegenerative diseases. Brain Nerve. 2008;60:157–70.
- Basso M, Samengo G, Nardo G, Massignan T, D'Aless-andro G, Tartari S, . Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. PloS One. 2009;4:8130.
- Liu D, Bao F, Wen J, Liu J. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis. Neuroscience. 2007;146:255–64.
- Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Zetterberg H, Jacobsson J, Rosengren L, Blennow K, Andersen PM. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur J Neurol. 2007;14:1329–33.
- Norgren N, Rosengren L, Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Res. 2003;987:25–31.
- Boylan K, Yang C, Crook J, Overstreet K, Heckman M, Wang Y, . Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J Neurochem. 2009; 111:1182–91.
- Brettschneider J, Petzold A, Süssmuth SD, Ludolph AC, Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 2006;66:852–6.
- Ryberg H, Söderling AS, Davidsson P, Blennow K, Caidahl K, Persson LI. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease. Neurochem Int. 2004;45:57–62.